BACKGROUND/AIMS: Measures of functional status are used in the general population to aid prognostication but their use has not been explored in pre-dialysis chronic kidney disease (CKD). This analysis considers the association between the Karnofsky performance score (KPS) and all-cause mortality in a CKD stage 3-5 cohort. METHODS: Patients were selected from the Chronic Renal Insufficiency Standards Implementation Study (CRISIS), a prospective observational study of outcome in CKD. Risk for death was assessed using multivariate Cox regression, and differences in progression of biochemical parameters were considered in a mixed-effects model. RESULTS: A total of 1,515 patients with a median follow-up time of 2.9 (1.5-4.8) years were considered. Baseline age was 60 ± 11 years and eGFR was 30 ± 12 ml/min/1.73 m(2). Patients with a reduced KPS had an increased risk for death. The hazard ratio (HR) for death was: KPS 90 group, HR 1.2 (95% CI 0.9-1.5), p = 0.1; KPS ≤ 80 group, HR 1.8 (95% CI 1.4-2.4), p < 0.001. In the mixed-effects model, the average annual loss of eGFR was greater in patients with a KPS ≤ 80 versus patients with a KPS >80 (5 vs. 3%, p = 0.008). CONCLUSION: A reduced KPS is independently associated with risk for mortality in patients with CKD stages 3-5. This may relate to a more rapid loss of eGFR.
BACKGROUND/AIMS: Measures of functional status are used in the general population to aid prognostication but their use has not been explored in pre-dialysis chronic kidney disease (CKD). This analysis considers the association between the Karnofsky performance score (KPS) and all-cause mortality in a CKD stage 3-5 cohort. METHODS:Patients were selected from the Chronic Renal Insufficiency Standards Implementation Study (CRISIS), a prospective observational study of outcome in CKD. Risk for death was assessed using multivariate Cox regression, and differences in progression of biochemical parameters were considered in a mixed-effects model. RESULTS: A total of 1,515 patients with a median follow-up time of 2.9 (1.5-4.8) years were considered. Baseline age was 60 ± 11 years and eGFR was 30 ± 12 ml/min/1.73 m(2). Patients with a reduced KPS had an increased risk for death. The hazard ratio (HR) for death was: KPS 90 group, HR 1.2 (95% CI 0.9-1.5), p = 0.1; KPS ≤ 80 group, HR 1.8 (95% CI 1.4-2.4), p < 0.001. In the mixed-effects model, the average annual loss of eGFR was greater in patients with a KPS ≤ 80 versus patients with a KPS >80 (5 vs. 3%, p = 0.008). CONCLUSION: A reduced KPS is independently associated with risk for mortality in patients with CKD stages 3-5. This may relate to a more rapid loss of eGFR.
Authors: Jennifer S Scherer; Katherine Harwood; Julia L Frydman; Derek Moriyama; Abraham A Brody; Frank Modersitzki; Caroline S Blaum; Joshua Chodosh Journal: J Palliat Med Date: 2019-07-11 Impact factor: 2.947
Authors: Cécile Couchoud; Brenda Hemmelgarn; Peter Kotanko; Michael J Germain; Olivier Moranne; Sara N Davison Journal: Clin J Am Soc Nephrol Date: 2016-08-10 Impact factor: 8.237
Authors: Sara T Ibrahim; Rajkumar Chinnadurai; Ibrahim Ali; Debbie Payne; Gillian I Rice; William G Newman; Eman Algohary; Ahmed G Adam; Philip A Kalra Journal: PLoS One Date: 2020-01-31 Impact factor: 3.240
Authors: Venceslau A Coelho; Giovani Gn Santos; Carla M Avesani; Cicero Italo L Bezerra; Luana Cristina A Silva; Julia C Lauar; Bengt Lindholm; Peter Stenvinkel; Wilson Jacob-Filho; Irene L Noronha; Roberto Zatz; Rosa M A Moysés; Rosilene M Elias Journal: BMC Nephrol Date: 2020-11-07 Impact factor: 2.388
Authors: Henry H L Wu; Reinier Van Mierlo; George McLauchlan; Kirsty Challen; Sandip Mitra; Ajay P Dhaygude; Andrew C Nixon Journal: Int Urol Nephrol Date: 2021-03-08 Impact factor: 2.370